Den Europæiske Union - dansk - EMA (European Medicines Agency)

novo nordisk a/s - semaglutid - obesity; overweight - antiobesity preparations, excl. diætprodukter - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

gilead sciences ireland uc - emtricitabine, tenofovir alafenamide - hiv infektioner - antivirale midler til systemisk anvendelse - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv-1).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sanofi winthrop industrie - lixisenatid - diabetes mellitus, type 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

accord healthcare s.l.u. - relugolix - prostatiske neoplasmer - endokrine terapi - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatid - osteoporosis; osteoporosis, postmenopausal - calciumhomeostase - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

mylan pharmaceuticals limited - entecavir monohydrat - hepatitis b - antivirale midler til systemisk anvendelse - entecavir mylan is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with:compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. dekompenseret leversygdom. for både erstatning og dekompenseret leversygdom, denne angivelse er baseret på data fra kliniske forsøg i nukleosid naive patienter med hbeag-positive og hbeag negativ hbv-infektion. med hensyn til patienter med lamivudin-ildfast hepatitis b. entecavir mylan er også indiceret til behandling af kronisk hbv infektion i nukleosid naive pædiatriske patienter fra 2 til.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

baxter holding b.v. - insulin human (rdna) - diabetes mellitus - narkotika anvendt i diabetes - inpremzia is indicated for the treatment of diabetes mellitus.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - oftalmologiske - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

accord healthcare s.l.u. - entecavir - hepatitis b, kronisk - antivirale midler til systemisk anvendelse - entecavir accord is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: , compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. , dekompenseret leversygdom. for både erstatning og dekompenseret leversygdom, denne angivelse er baseret på data fra kliniske forsøg i nukleosid naive patienter med hbeag-positive og hbeag negativ hbv-infektion. med hensyn til patienter med lamivudin-ildfast hepatitis b. entecavir accord er også indiceret til behandling af kronisk hbv infektion i nukleosid naive pædiatriske patienter fra 2 til.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

eurogenerics holdings b.v. - teriparatid - osteoporose - calciumhomeostase - qutavina is indicated in adults. behandling af osteoporose hos postmenopausale kvinder og hos mænd med øget risiko for brud. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. behandling af osteoporose, der er forbundet med vedvarende systemisk glukokortikoid behandling, kvinder og mænd med øget risiko for fraktur.